查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080364

兒童醫療保健市場：2026-2032年全球市場預測（依產品類型、給藥途徑、病患年齡層、疾病類型、適應症及給藥方式分類）

Paediatric Healthcare Market by Product Type, Route Of Administration, Patient Age Group, Type of Illness, Inidication, Delivery Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，兒童醫療保健市場將成長至 2,092.9 億美元，複合年成長率為 7.83%。

主要市場統計數據
基準年 2025 1234.5億美元
預計年份：2026年 1313.8億美元
預測年份 2032 2092.9億美元
複合年成長率 (%) 7.83%

兒童保健正從孤立的治療轉向綜合性、預防性和數位化驅動的兒童醫療保健服務。這種需求有可衡量的現實支撐。根據聯合國兒童基金會統計，2022年有490萬五歲以下兒童死亡，而世界衛生組織仍將新生兒併發症、肺炎、腹瀉、瘧疾、創傷和出生缺陷列為兒童醫療保健的首要挑戰。

其他成長要素包括疫苗接種率的恢復、兒童慢性疾病的管理、對行為健康的需求以及以家庭為中心的照護模式。對於行業領導者而言，醫療保健市場越來越依賴醫療服務的可及性、治療效果、人才引進、與保險報銷系統的銜接以及可靠的數位基礎設施。

兒童醫療保健領域發生的變革性變化

預防醫學、門診治療模式的轉變、遠端醫療、家庭監測以及基於價值的報銷機制正在重塑兒童醫療保健格局。世界衛生組織和聯合國兒童基金會的免疫接種數據顯示，數百萬兒童仍未接種疫苗或接種不足，凸顯了疫苗接種、基層醫療網路和校內保健在商業性和公共衛生方面的重要性。

人工智慧在兒童醫學中的累積影響

人工智慧 (AI) 透過改善分流、診斷影像、臨床文件記錄、人群健康分析、疫苗接種活動和營運規劃，對整體兒童醫療保健產生了累積的影響。在人工監督下實施時，人工智慧工具可以幫助臨床醫生及早發現病情惡化、進行個人化風險分層並減輕行政負擔。

醫療保健市場的關鍵區域洞察

亞太地區擁有全球最多的兒童人口，但兒童專科醫生資源分配不均，因此，可擴展的基層醫療、疫苗接種、新生兒護理和遠端醫療成為關鍵的成長要素。中國和印度是服務提供的基礎，而日本、韓國、新加坡和澳洲則在先進的兒童醫院、數位醫療和精準診斷方面處於領先地位。該地區的優先事項與世界衛生組織的兒童生存目標、國家免疫規劃和擴大公共衛生覆蓋範圍的目標密切相關。

針對特定族群的醫療保健策略關鍵見解

東協兒童醫療保健的特點是全民健保（UHC）的擴展、都市區醫院的現代化以及農村地區醫療服務取得差距的持續存在，這催生了對價格合理的診斷、免疫基礎設施、行動醫療模式和社區基層醫療的需求。根據國家轉型議程，海灣合作理事會（GCC）成員國正在投資建造三級兒童醫療設施、醫療旅遊系統、數位醫療平台以及專業醫療人員的培訓。

來自兒童醫療保健主要國家的見解

美國在兒童專科護理、生物醫學研究經費、新生兒主導監護和數位醫療應用方面處於領先地位，而加拿大則優先考慮全民醫療保健、兒童健康公平以及農村和偏遠地區的醫療服務。墨西哥和巴西正在擴大公共兒童醫療保險覆蓋範圍、免疫接種計劃以及婦幼保健服務，但在獲得專科醫生、診斷和後續護理方面仍然存在區域差異。

為兒童醫療保健領域的領導者提供的實用建議

產業領導者應優先考慮兒童領域的證據產生、公平取得和可衡量的療效。投資應重點關注免疫接種覆蓋率、新生兒和母嬰保健整合、心理健康支持、慢性病管理、罕見疾病治療路徑以及為患有複雜疾病的兒童協調護理。

調查方法

本執行摘要是根據全球公認的公共衛生和醫療保健資訊來源的二手研究，包括世界衛生組織、聯合國兒童基金會、美國疾病管制與預防中心、經濟合作暨發展組織、世界銀行、各國衛生組織以及同行評審的兒童醫學文獻。分析重點檢驗的指標，例如兒童死亡率、免疫接種率、疾病負擔、醫療保健成本、醫護人員能力、醫療服務取得差異以及監管方向。

結論

兒童醫療保健正進入一個關鍵階段，預防、數位轉型、專科護理和健康公平在此交匯融合。最大的機會在於已證實存在的兒童健康需求，包括免疫接種、新生兒生存、慢性病管理、青少年心理健康、罕見疾病護理以及複雜疾病的協調護理。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章兒童醫療保健市場：依產品類型分類

  • 醫療器材
    • 新生兒護理設備
    • 手術器械
    • 監控設備
  • 製藥
    • 疫苗
    • 營養補充品和維生素
    • 抗生素和抗病毒藥物

第8章兒童醫療保健市場：依給藥途徑分類

  • 口服
  • 腸外
    • 肌肉內部
    • 靜脈
    • 皮下
  • 外用
    • 皮膚科
    • 鼻內
    • 眼科
  • 經皮給藥

第9章兒童醫療保健市場：依病患年齡層別分類

  • 新生兒（0-28天）
  • 嬰兒（1個月至1歲）
  • 幼兒（1-3歲）
  • 兒童（4-12歲）

第10章兒童醫療保健市場：依疾病類型分類

  • 急性病
  • 慢性病

第11章兒童醫療保健市場：依適應症分類

  • 消化系統疾病
    • 腹瀉
    • 吸收不良
  • 遺傳性疾病
  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 病毒感染疾病
  • 神經病變
    • ADHD
    • 腦性麻痹
    • 癲癇
  • 呼吸系統疾病
    • 氣喘
    • 支氣管炎
    • 肺炎

第12章兒童醫療保健市場：依服務模式分類

  • 居家照護
    • 傳統的家庭醫療服務
    • 遠端醫療
  • 住院治療
  • 門診
    • 門診手術
    • 日托

第13章兒童醫療保健市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章兒童醫療保健市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章兒童醫療保健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Aveanna Healthcare Holdings Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • BioMarin Pharmaceutical Inc.
  • Blueberry Pediatrics
  • Bobbie Baby, Inc.
  • Boston Scientific Corporation
  • Cipla Limited
  • Danone SA
  • Danone SA
  • Dr. Reddy's Laboratories Limited
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KidsCare Home Health, LLC
  • Masimo Corporation
  • Medtronic plc
  • Nestle SA
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Roche Holding AG
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
Product Code: MRR-434CCDA04E27

The Paediatric Healthcare Market is projected to grow by USD 209.29 billion at a CAGR of 7.83% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 123.45 billion
Estimated Year [2026] USD 131.38 billion
Forecast Year [2032] USD 209.29 billion
CAGR (%) 7.83%

Paediatric healthcare is shifting from episodic treatment to integrated, preventive, and digitally enabled child health services. Demand is anchored in measurable needs: UNICEF reported 4.9 million under-five deaths in 2022, while WHO identifies neonatal complications, pneumonia, diarrhoea, malaria, injuries, and congenital conditions as persistent child health priorities.

Growth is also shaped by vaccination recovery, paediatric chronic disease management, behavioural health demand, and family-centred care models. For industry leaders, the paediatric healthcare market increasingly depends on access, outcomes, workforce capacity, reimbursement alignment, and trusted digital infrastructure.

Transformative Shifts in the Paediatric Healthcare Landscape

The paediatric care landscape is being reshaped by preventive health, outpatient migration, virtual care, genomics, home-based monitoring, and value-based reimbursement. WHO and UNICEF immunization data show that millions of children remain zero-dose or under-immunized, reinforcing the commercial and public health importance of vaccine delivery, primary care networks, and school-linked care.

At the same time, paediatric hospitals are treating more medically complex children who survive prematurity, congenital disorders, and cancer. This is driving demand for multidisciplinary care coordination, paediatric specialty capacity, remote patient monitoring, and interoperable records that follow children across settings.

Cumulative Impact of Artificial Intelligence in Paediatric Care

Artificial intelligence is creating cumulative impact across paediatric healthcare by improving triage, imaging interpretation, clinical documentation, population health analytics, vaccine outreach, and operational planning. AI-enabled tools can help clinicians identify deterioration earlier, personalize risk stratification, and reduce administrative burden when implemented with human oversight.

However, paediatric AI requires stricter validation because children differ physiologically from adults and many algorithms are trained on adult-heavy datasets. Leaders must prioritize explainability, equity testing, data privacy, paediatric-specific clinical trials, and regulator-aligned governance to prevent bias and ensure safe adoption.

Key Regional Insights Across Paediatric Healthcare Markets

Asia-Pacific combines the world's largest child populations with uneven access to paediatric specialists, making scalable primary care, vaccines, neonatal care, and telehealth central growth drivers. China and India anchor service volume, while Japan, South Korea, Singapore, and Australia lead in advanced paediatric hospitals, digital health, and precision diagnostics. The region's priorities align closely with WHO child survival goals, national immunization programs, and expanding public insurance coverage.

North America benefits from high healthcare spending, strong paediatric research networks, established neonatal and specialty care infrastructure, and rapid digital health adoption. Europe is shaped by universal coverage, health technology assessment, paediatric medicine regulation, and strict data protection requirements. Latin America is advancing immunization, maternal-child health, and primary care programs but continues to face access disparities between urban and rural populations.

The Middle East, led by GCC health-system investment, is expanding tertiary paediatric hospitals, digital health platforms, and specialty care capacity as part of broader health transformation strategies. Africa remains focused on reducing preventable child mortality, improving immunization coverage, strengthening neonatal and maternal care, and expanding trained workforce capacity, with WHO and UNICEF data continuing to highlight pneumonia, malaria, diarrhoea, and neonatal conditions as major child health priorities.

Key Group Insights for Paediatric Healthcare Strategy

ASEAN paediatric healthcare is defined by expanding universal health coverage, urban hospital modernization, and continued rural access gaps, creating demand for affordable diagnostics, immunization infrastructure, mobile care models, and community-based primary care. GCC countries are investing in tertiary paediatric facilities, medical travel capabilities, digital health platforms, and specialty workforce development under national transformation agendas.

The European Union emphasizes paediatric medicine regulation, pharmacovigilance, cross-border health data, evidence-based reimbursement, and equity in access to child health services. BRICS countries combine large birth cohorts with rising middle-class demand and public health priorities, making scalability, affordability, vaccine delivery, neonatal care, and specialist access essential. G7 markets lead in paediatric innovation, specialty pharmaceuticals, clinical research, digital health integration, and quality measurement, while NATO members increasingly emphasize health-system resilience, supply security, emergency preparedness, and continuity of care for children during crises.

Key Country Insights in Paediatric Healthcare

The United States leads in paediatric specialty care, biomedical research funding, neonatal intensive care, and digital health adoption, while Canada emphasizes universal access, child health equity, and rural or remote service delivery. Mexico and Brazil are expanding public child health coverage, vaccination programs, and maternal-child services but continue to face regional disparities in specialist access, diagnostics, and continuity of care.

The United Kingdom, Germany, France, Italy, and Spain combine strong immunization programs, established paediatric systems, and evidence-based reimbursement with pressure from workforce shortages, waiting lists, and budget constraints. Russia maintains broad paediatric infrastructure and immunization capacity but faces modernization, regional access, and technology integration challenges.

China and India represent the largest paediatric demand pools, with priorities spanning neonatal survival, vaccination, nutrition, infectious disease control, chronic disease management, and specialty care access. Japan, Australia, and South Korea show advanced paediatric quality systems, high digital readiness, and growing attention to child and adolescent mental health, while also managing budget pressures linked to demographic change and rising complexity of care.

Actionable Recommendations for Paediatric Healthcare Leaders

Industry leaders should prioritize paediatric-specific evidence generation, equitable access, and measurable outcomes. Investments should focus on vaccination reach, neonatal and maternal-child integration, mental health capacity, chronic disease management, rare disease pathways, and care coordination for medically complex children.

Commercial strategies should align with payer expectations for value, safety, and interoperability. Organizations should build paediatric AI governance, expand telehealth with in-person referral pathways, partner with schools and community providers, and localize product design for affordability, language, caregiver engagement, and regulatory requirements.

Research Methodology

This executive summary is grounded in secondary research from globally recognized public health and healthcare sources, including WHO, UNICEF, CDC, OECD, World Bank, national health agencies, and peer-reviewed paediatric literature. The analysis prioritizes verified indicators such as child mortality, immunization coverage, disease burden, healthcare spending, workforce capacity, access gaps, and regulatory direction.

Insights were synthesized through market segmentation, regional comparison, policy review, technology assessment, and demand-driver mapping. The methodology excludes unsupported claims and avoids market estimation, sizing, share, and forecasting, emphasizing reproducible, data-backed interpretation suitable for paediatric healthcare executives, investors, providers, policymakers, and digital health innovators.

Conclusion

Paediatric healthcare is entering a decisive phase in which prevention, digital transformation, specialty care, and health equity converge. The strongest opportunities are tied to proven child health needs, including immunization, neonatal survival, chronic disease management, adolescent mental health, rare disease care, and coordinated care for complex conditions.

Organizations that combine clinical credibility, paediatric-specific data, responsible AI, and regionally tailored access models will be best positioned to improve performance. Sustainable leadership will depend on improving outcomes for children while meeting payer, regulator, provider, and caregiver expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Paediatric Healthcare Market, by Product Type

  • 7.1. Medical Devices
    • 7.1.1. Neonatal Care Devices
    • 7.1.2. Surgical Instruments
    • 7.1.3. Monitoring Devices
  • 7.2. Pharmaceuticals
    • 7.2.1. Vaccines
    • 7.2.2. Nutritional Supplements & Vitamins
    • 7.2.3. Antibiotics & Antivirals

8. Paediatric Healthcare Market, by Route Of Administration

  • 8.1. Oral
  • 8.2. Parenteral
    • 8.2.1. Intramuscular
    • 8.2.2. Intravenous
    • 8.2.3. Subcutaneous
  • 8.3. Topical
    • 8.3.1. Dermatological
    • 8.3.2. Nasal
    • 8.3.3. Ophthalmic
  • 8.4. Transdermal

9. Paediatric Healthcare Market, by Patient Age Group

  • 9.1. Neonates (0-28 days)
  • 9.2. Infants (1 month-1 year)
  • 9.3. Toddlers (1-3 years)
  • 9.4. Children (4-12 years)

10. Paediatric Healthcare Market, by Type of Illness

  • 10.1. Acute Illnesses
  • 10.2. Chronic Illnesses

11. Paediatric Healthcare Market, by Inidication

  • 11.1. Gastrointestinal Disorders
    • 11.1.1. Diarrhea
    • 11.1.2. Malabsorption
  • 11.2. Genetic Disorders
  • 11.3. Infectious Diseases
    • 11.3.1. Bacterial Infections
    • 11.3.2. Fungal Infections
    • 11.3.3. Viral Infections
  • 11.4. Neurological Disorders
    • 11.4.1. ADHD
    • 11.4.2. Cerebral Palsy
    • 11.4.3. Epilepsy
  • 11.5. Respiratory Disorders
    • 11.5.1. Asthma
    • 11.5.2. Bronchitis
    • 11.5.3. Pneumonia

12. Paediatric Healthcare Market, by Delivery Mode

  • 12.1. Home Care
    • 12.1.1. Conventional Home Visit
    • 12.1.2. Telehealth
  • 12.2. Inpatient
  • 12.3. Outpatient
    • 12.3.1. Ambulatory Surgery
    • 12.3.2. Day Care

13. Paediatric Healthcare Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Paediatric Healthcare Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Paediatric Healthcare Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. AbbVie Inc.
  • 17.3. Amgen Inc.
  • 17.4. Aveanna Healthcare Holdings Inc.
  • 17.5. Bayer AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. BioMarin Pharmaceutical Inc.
  • 17.8. Blueberry Pediatrics
  • 17.9. Bobbie Baby, Inc.
  • 17.10. Boston Scientific Corporation
  • 17.11. Cipla Limited
  • 17.12. Danone S.A.
  • 17.13. Danone S.A.
  • 17.14. Dr. Reddy's Laboratories Limited
  • 17.15. Eli Lilly and Company
  • 17.16. GlaxoSmithKline plc
  • 17.17. Johnson & Johnson
  • 17.18. KidsCare Home Health, LLC
  • 17.19. Masimo Corporation
  • 17.20. Medtronic plc
  • 17.21. Nestle S.A.
  • 17.22. Novartis AG
  • 17.23. Pfizer Inc.
  • 17.24. Reckitt Benckiser Group plc
  • 17.25. Roche Holding AG
  • 17.26. Sanofi S.A.
  • 17.27. Serum Institute of India Pvt. Ltd.
  • 17.28. Takeda Pharmaceutical Company Limited
  • 17.29. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PAEDIATRIC HEALTHCARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PAEDIATRIC HEALTHCARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEONATAL CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUTRITIONAL SUPPLEMENTS & VITAMINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTIBIOTICS & ANTIVIRALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DERMATOLOGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DERMATOLOGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DERMATOLOGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NASAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NASAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NASAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEONATES (0-28 DAYS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INFANTS (1 MONTH-1 YEAR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TODDLERS (1-3 YEARS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CHILDREN (4-12 YEARS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE ILLNESSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CHRONIC ILLNESSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIARRHEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIARRHEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIARRHEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MALABSORPTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MALABSORPTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MALABSORPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ADHD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ADHD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ADHD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CEREBRAL PALSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CEREBRAL PALSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CEREBRAL PALSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ASTHMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ASTHMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ASTHMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRONCHITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BRONCHITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRONCHITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PNEUMONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PNEUMONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PNEUMONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONVENTIONAL HOME VISIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL AMBULATORY SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DAY CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DAY CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DAY CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 282. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 285. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 286. GCC PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 321. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 326. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 327. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 328. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 329. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 330. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 331. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 332. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 333. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 334. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 335. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 336. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 337. G7 PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 338. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 339. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 342. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 343. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 344. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 345. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 346. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TYPE OF ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 347. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2032 (USD MILLION)
  • TABLE 348. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 349. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 350. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 351. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 352. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 353. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 354. NATO PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 355. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE